سينوس جي علاج واري دوائن جي مارڪيٽ 4.29 جي آخر تائين 2030 بلين ڊالر تائين پهچي ويندي

The development of biologics is amongst the most important factors catalysing the sinus therapeutic drugs market. Omalizumab is garnering interest of researchers and drug manufacturers alike. It has obtained the approval all across the Europe and the US to treat severe allergic asthma.

In adults, sinus infections could be attributed to sinus glands having structural deformities, nasal polyps, and history of infection to respiratory tract, weakened immunity.

In children, sinus-related infections could be caused due to a pacifier, getting unduly exposed to second-hand smoke, feeding at the time of laying down, and likewise. Moreover, fungal infections and pollutants drive sinusitis.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12367

Key Participant Insights

The global market is set to witness a staggering growth in the forecast period. The market players are batting for organic as well as inorganic mode of expansion.

For instance –

• In Jul 2020, Tiziana announced submission of patent application for Foralumab’s nasal administration. Foralumab is a 100% human Anti-CD3 monoclonal antibody to treat Covid-19 patients.
• In Jun 2019, Sanofi and Regeneron Pharmaceuticals, Inc. announced approval of Dupixent (dupilumab) by the US FDA to be used with the other medicines for treating CRSwNP (chronic rhinosinusitis with nasal polyposis).

The key market players covered by FMI include Bausch Health, Nоvаrtіѕ АG, Ѕun Рhаrmасеutісаl Іnduѕtrіеѕ, Іnс., Rеddу’ѕ Lаbоrаtоrіеѕ, Іnс., Теа Рhаrmасеutісаl Іnduѕtrіеѕ Ltd., Frеѕеnіuѕ Каbі UЅА, Јоhnѕоn & Јоhnѕоn, Рfіzеr Іnс., Јаnѕѕеn Рhаrmасеutісаlѕ, Іnс., and GlaxoSmithKline plc.

انگن اکرن سان هن رپورٽ جي مڪمل TOC جي درخواست ڪريو: https://www.futuremarketinsights.com/toc/rep-gb-12367

ڪيٻئي جا رستا

• Steroid nasal sprays held the largest market share in 2019 and the scenario is expected to continue in the upcoming period as well.
• North America accounted for more than 30% of market share in 2019
• Antibiotics remain a first line of defence, and this category is likely to grow at steady pace through 2030
• Covid-19 outbreak has diverted the research towards nasal drug delivery, which is likely to benefit even sinus therapeutic drugs market.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global sinus therapeutic drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on sinus therapeutic drugs market on the basis of drug class (Аntіhіѕtаmіnеѕ, Аnаlgеѕісѕ, Ѕulрhоnаmіdеѕ, Соrtісоѕtеrоіdѕ, Аntіbіоtісѕ, NSAID’s, and Оthеr Drug Сlаѕѕеѕ), type of disease (Acute Sinusitis, Sub-acute Sinusitis, Chronic Sinusitis), route of administration (Oral, Topical, Injectable), and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies) across seven major regions

مکيه ڀاڱو

انتظاميه جو رستو

تقسيم چينل

• اسپتال جي فارميسي
• پرچون فارميسي
• آن لائن فارميسي

مرض جو قسم

• Acute Sinusitis
• Sub-acute Sinusitis
• Chronic Sinusitis

جاگرافي

• اتر آمريڪا
• لاطيني آمريڪا
• يورپ
• اوڀر ايشيا
• ڏکڻ ايشيا
• اوڪريا
• وچ اوڀر ۽ آفريڪا

مستقبل جي مارڪيٽ بصيرت بابت (FMI)
فيوچر مارڪيٽ بصيرت (ESOMAR تصديق ٿيل مارڪيٽ ريسرچ آرگنائيزيشن ۽ گريٽر نيو يارڪ چيمبر آف ڪامرس جو ميمبر) مارڪيٽ ۾ طلب کي بلند ڪرڻ لاءِ گورننگ فڪٽرن ۾ گہرا بصيرت مهيا ڪري ٿي. اهو موقعن کي ظاهر ڪري ٿو جيڪي مختلف حصن ۾ مارڪيٽ جي ترقي کي هٿي ڏين ٿا ذريعن جي بنياد تي، ايپليڪيشن، سيلز چينل ۽ ايندڙ 10 سالن ۾ آخري استعمال.

اسان سان رابطو ڪريو:

تازي مارڪيٽ جي منتقلي
يونٽ نمبر: 1602-006، جميرا بي 2، پلاٽ نمبر: JLT-PH2-X2A

جميرا ڍنڍ ٽاورز، دبئي

متحده عرب امارات

LinkedIn،| Twitter| رڪن